{"version":"1.0","provider_name":"Nanexa AB","provider_url":"https:\/\/nanexa.com\/sv\/","title":"Del\u00e5rsrapport Januari \u2013 September 2020 - Nanexa AB","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"1ISSqpR8iJ\"><a href=\"https:\/\/nanexa.com\/sv\/mfn_news\/delarsrapport-januari-september-2020\/\">Del\u00e5rsrapport Januari \u2013 September 2020<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/nanexa.com\/sv\/mfn_news\/delarsrapport-januari-september-2020\/embed\/#?secret=1ISSqpR8iJ\" width=\"600\" height=\"338\" title=\"\u201dDel\u00e5rsrapport Januari \u2013 September 2020\u201d &ndash; Nanexa AB\" data-secret=\"1ISSqpR8iJ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/nanexa.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"\"Nanexas tredje kvartal var planenligt ett kvartal av intensiva f\u00f6rberedelser i en mycket positiv anda. Vi gjorde fortsatta framsteg, framf\u00f6rallt n\u00e4r det g\u00e4llde v\u00e5rt eget projekt NEX-18 f\u00f6r f\u00f6rb\u00e4ttrad behandling av MDS, en form av leukemi. En grundsten f\u00f6r NEX-18-projektet \u00e4r ett tillst\u00e5nd f\u00f6r att f\u00e5 tillverka kliniskt pr\u00f6vningsmaterial som bygger p\u00e5 att materialet tillverkas i enlighet med GMP (Good Manufacturing Practice). Det var d\u00e4rf\u00f6r mycket gl\u00e4djande att efter kvartalets utg\u00e5ng kunna meddela att Nanexa erh\u00e5llit detta GMP-certifikat fr\u00e5n L\u00e4kemedelsverket.\" David Westberg, vd Nanexa AB."}